Cambridge Nuclear Corp.
United StatesFDA applicant, unverified
- Devices
- 5
What Cambridge Nuclear Corp. makes
Cambridge Nuclear Corp. manufactures diagnostic kits and immunoassay reagents for measuring hormone levels in clinical settings, including estriol, testosterone, and progesterone. Their portfolio also includes antisera for research applications, such as bradykinin and anti-bradykinin antisera.
These products are classified as Class I medical devices under FDA regulations and are supported by 510(k) clearances. The company operates from the United States.
Catalogue
Estriol Kit Ref K811380
Regimes: 510(k) Registry: 510(k)I Testoterone Ref K790007
Regimes: 510(k) Registry: 510(k)I Bradykinin & Anti-Bradykinin Antiserum Ref K790362
Regimes: 510(k) Registry: 510(k)Progesterone Kit Ref K810804
Regimes: 510(k) Registry: 510(k)I Estriol Ref K790008
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Cambridge Nuclear Corp. have in the registry?
The registry currently lists 5 devices for Cambridge Nuclear Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cambridge Nuclear Corp.'s devices?
Among its 5 most recently registered devices, Cambridge Nuclear Corp. has devices listed in FDA 510(k) (5 devices).
What risk classes do Cambridge Nuclear Corp.'s devices fall under?
Among its 5 most recently registered devices, the classes recorded for Cambridge Nuclear Corp.'s devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Cambridge Nuclear Corp. in the registry?
The most recently registered devices listed for Cambridge Nuclear Corp. include ESTRIOL KIT, I TESTOTERONE, I BRADYKININ & ANTI-BRADYKININ ANTISERUM and PROGESTERONE KIT.